Welcome commitment from Australian Government to improve patient access to essential medicines for opioid dependence treatment
Penington Institute firmly welcomes the announcement in the 2023-24 Budget that the Australian Government will commit $377.3 million dollars over 4 years to improving access to opioid dependence treatment medicines under the Pharmaceutical Benefits Scheme (PBS). This commitment will significantly improve affordability and access to these essential medicines for tens of thousands of Australians. From […]
